Your session is about to expire
← Back to Search
Pulpotomy for Dental Pulp Disease
Study Summary
This trial found that intentional bioactive cement pulpotomies can help preserve vital and asymptomatic carious primary molars with gingival margins close to or at the CEJ.
- Dental Pulp Disease
- Tooth Decay
- Toothache
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is enrollment presently available for this investigation?
"Affirmative. According to the information provided by clinicaltrials.gov, this medical study is actively seeking participants since it was first published on June 12th 2020 and last updated on June 15th 2022. 30 patients will be welcomed at a single site for participation in the trial."
How many participants have been enrolled in this research endeavor?
"Affirmative, the information available on clinicaltrials.gov suggests that enrollment for this trial is currently open. Originally posted in June of 2020 and last edited in June 2022, 30 participants are needed at a single site."
Does this research study allow individuals over the age of eighty-five to participate?
"This clinical trial is focused on children between 5 and 10, though there are also 23 trials for younger children and 22 studies available to those over 65."
Am I eligible to volunteer for this medical trial?
"This trial is recruiting 30 participants aged 5 to 10 that have dental pulp diseases. The applicants must also meet certain conditions, such as having carious lesions within the cemento-enamel junction; teeth without swelling or sensitivity to percussion; adequate space for a stainless steel crown restoration and close proximity of lesion to the pulp with at least 1-2 mm of sound dentin separating them; no furcation pathology, internal/external root resorption or presence of half to two thirds remaining roots length."
Share this study with friends
Copy Link
Messenger